Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 20, 2014
Assessment of chimerism in epithelial cancers in transplanted patientsChristophe Leboeuf, Philippe Ratajczak, Jérôme Vérine, et al.
European Journal of Radiology|July 3, 2014
¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancerDavid Groheux, Elif Hindié, Michel Marty, et al.
Frontiers in Immunology|July 1, 2025
Characteristics and predictive model for diffuse large B-cell lymphoma with early chemoimmunotherapy failureYing-Yu Dong, Qing Shi, Wen Wu, et al.
Oncotarget|April 27, 2017
Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodesElise Furet, Morad El Bouchtaoui, Jean-Paul Feugeas, et al.
Springerplus|February 3, 2016
A phase II study of afatinib, an irreversible ErbB family blocker, added to letrozole in patients with estrogen receptor-positive hormone-refractory metastatic breast cancer progressing on letrozoleKatharina Gunzer, Florence Joly, Jean-Marc Ferrero, et al.
International Journal of Oncology|December 3, 2019
Drug resistance‑related sunitinib sequestration in autophagolysosomes of endothelial cellsShuang Wu, Limin Huang, Rong Shen, et al.
Cancer Chemotherapy and Pharmacology|September 25, 2013
Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosisGuilhem Bousquet, Mariana Varna, Irmine Ferreira, et al.
Oncotarget|May 24, 2015
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinomaGuilhem Bousquet, Morad El Bouchtaoui, Christophe Leboeuf, et al.
Oncotarget|May 15, 2020
Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancerTu Dao, Guillaume Gapihan, Christophe Leboeuf, et al.
International Journal of Molecular Sciences|December 16, 2018
Targeting Cancer Stem Cells to Overcome ChemoresistanceToni Nunes, Diaddin Hamdan, Christophe Leboeuf, et al.
Pageof 9